REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 51 filers reported holding REGULUS THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $97,000 | -70.2% | 492,878 | 0.0% | 0.01% | -69.7% |
| Q2 2018 | $325,000 | -8.2% | 492,878 | 0.0% | 0.03% | -25.0% |
| Q1 2018 | $354,000 | -31.0% | 492,878 | 0.0% | 0.04% | -36.2% |
| Q4 2017 | $513,000 | -29.2% | 492,878 | -15.0% | 0.07% | -25.8% |
| Q3 2017 | $725,000 | +23.9% | 580,000 | -2.3% | 0.09% | +10.7% |
| Q2 2017 | $585,000 | -40.2% | 593,629 | 0.0% | 0.08% | -45.8% |
| Q1 2017 | $979,000 | -7.0% | 593,629 | +26.8% | 0.16% | -23.3% |
| Q4 2016 | $1,053,000 | -99.9% | 468,175 | +56.1% | 0.20% | +28.7% |
| Q3 2016 | $990,000,000 | +97726.1% | 300,000 | -14.3% | 0.16% | -12.8% |
| Q2 2016 | $1,012,000 | -27.0% | 350,000 | +75.0% | 0.18% | -34.5% |
| Q1 2016 | $1,386,000 | -20.5% | 200,000 | 0.0% | 0.28% | +4.2% |
| Q4 2015 | $1,744,000 | +33.3% | 200,000 | 0.0% | 0.26% | +26.3% |
| Q3 2015 | $1,308,000 | – | 200,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
| Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
| ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
| Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
| Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
| Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
| DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
| ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |